-
29-05-2013, 02:54 PM
#191
Originally Posted by percy
Awesome.No I would never have believed it.
A great fit.
Exciting.
I'll second that, percy!
I have high regard for EBO management so assume there's a lot more to Symbion than "pharmaceutical wholesaler and distributor". It's not an exact comparison, but another big player, Sigma, has hardly been a roaring success in Australia for some time now as governments tighten drug subsidies/payments and competition intensifies. Not a true comparison, probably, as Sigma also has an extensive manufacturing and retail business, but I'd like to see some assurance that I'm just jumping at shadows here.
-
29-05-2013, 03:08 PM
#192
Who is buying who and who is paying for it
I must admit to wondering whether EBOS is buying Symbian or is Zuellig actually buying EBOS ?
Best Wishes
Paper Tiger
-
29-05-2013, 04:16 PM
#193
Originally Posted by Paper Tiger
I must admit to wondering whether EBOS is buying Symbian or is Zuellig actually buying EBOS ?
Best Wishes
Paper Tiger
Yes, although EBO is acquiring Symbion, Zeullig will end up with 40% of EBO and, as the independent report suggests, probable effective control of that company.
-
29-05-2013, 05:25 PM
#194
The market doesn't seem to have any doubts about the "merger". SP up 15c on resumption of trading.
-
30-05-2013, 02:44 PM
#195
Hope some of you traders were watching for the break out above $10 . Text book break out
-
30-05-2013, 04:06 PM
#196
Originally Posted by SparkyTheClown
Only offered 5000 shares, looks like some big scaling involved
Doing well, still worth $6500 based on ex price your broker just gave you.
-
31-05-2013, 07:07 AM
#197
Strange isn't it Percy - one of the bigger pieces of corporate activity to happen on nzx for years and hardly anybody makes comment
Spouse EBO even mor boring than that rym
-
31-05-2013, 07:22 AM
#198
Been good coverage in The Press.The more I read about it the more I like it.Bonus,and cash issue excellent for shareholders.Future earnings per share is surprisingly high.A very sound,strong company going forward.Australian listing may be good,I don't know.Head office staying in ChCh and Waller still in charge also surprised me.Both companies are very well run,so putting them together will result in even a better company.EBO learnt a lot from Zuellig run PRNZ ,so would expect the same this time. Symbion CEO Patrick Davies will be a welcome addition to the management team.
-
31-05-2013, 08:15 AM
#199
$10.60 what a vote of confidence!
Is the 7 for 20 rights issue going to be at $8.50 the same price as the institutional offer?
Think holders can apply for extra rights to take up any under subscriptions.
I'll tidy up my finances to make sure I can take up all my rights & maybe pick up some extras.
This has to be one of the better companies I've invested in over the last 35 years.
Started accumulating in August 2004 at $3.70
Good dividend yields based on that purchase price too.
It is one of the few stocks I never found a reason to sell!
-
31-05-2013, 08:29 AM
#200
Originally Posted by glennj
$10.60 what a vote of confidence!
Is the 7 for 20 rights issue going to be at $8.50 the same price as the institutional offer?
Think holders can apply for extra rights to take up any under subscriptions.
I'll tidy up my finances to make sure I can take up all my rights & maybe pick up some extras.
This has to be one of the better companies I've invested in over the last 35 years.
Started accumulating in August 2004 at $3.70
Good dividend yields based on that purchase price too.
It is one of the few stocks I never found a reason to sell!
7 for 20 is at $6.50.yes 6.50.
There is also a taxable bonus issue of 2 for 53 to make use of imputation credits that would be lost.record date 6th june.
Rights are tradeable.So I can't see that we can apply for extra.
Last edited by percy; 31-05-2013 at 08:32 AM.
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks